Evidence map›Paper›PMID 36285019›Full record

ArticleJournal of clinical and translational science2022

Conducting a pediatric randomized clinical trial during a pandemic: A shift to virtual procedures.

James R Roberts, Sheva K Chervinskiy, Russell McCulloh, Jessica Snowden, Paul M Darden, Thao-Ly T Phan, Erin Dawley, Victoria Reynolds, Crystal S Lim, Lee Pyles and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical and translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The impact of rural status on pediatric chronic kidney disease.Pediatric nephrology (Berlin, Germany) · 2024
    Article
  12. Narrative review of telemedicine applications in decentralized research.Journal of clinical and translational science · 2024
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

James R RobertsMedical University of South Carolina, Charleston, SC, USA.
Sheva K ChervinskiyUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Russell McCullohUniversity of Nebraska Medical Center, Omaha, NE, USA.
Jessica SnowdenUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID https://orcid.org/0000-0002-0715-151X
Paul M DardenUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Thao-Ly T PhanNemours Children's Health, Wilmington, DE, USA.
Erin DawleyMedical University of South Carolina, Charleston, SC, USA.
Victoria ReynoldsWest Virginia University, Morgantown, WV, USA.
Crystal S LimUniversity of Mississippi Medical Center, Jackson, MS, USA.
Lee PylesWest Virginia University, Morgantown, WV, USA.
DeAnn HubberdUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Jaime BaldnerUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID https://orcid.org/0000-0001-9660-4703
Lora LawrenceUniversity of Arkansas for Medical Sciences, Little Rock, AR, USA.
Ann M DavisCenter for Children's Healthy Lifestyles & Nutrition, Kansas City, MO, USA.
University of Arkansas for Medical Sciences · USMedical University of South Carolina · USWest Virginia University · USCenter for Children · USJackson Memorial Hospital · USNemours Children's Health System · USUniversity of Nebraska Medical Center · USUniversity of Oklahoma Health Sciences Center · US

Funding

Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials NetworkU24OD024957 · OD · UNIV OF ARKANSAS FOR MED SCIS · PI COURTNEY, SHERRY, OUNPRASEUTH, SONGTHIP T. · 2016 to 2024
$80.8M
MS-ISPCTN (Cycle 3)UG1OD024942 · OD · UNIVERSITY OF MISSISSIPPI MED CTR · PI Joseph Marc Majure · 2016 to 2026
$4.7M
Sunflower Pediatric Clinical Trials (SPeCTr 3.0)UG1OD024943 · OD · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Ann M Davis, BRIDGETTE L. JONES · 2016 to 2026
$4.7M
The DE Nemours/duPont Hospital for Children IDeA States Pediatric Clinical Trials Network SiteUG1OD024958 · OD · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI Robert E Akins, Thao-Ly Tam Phan-Vo · 2016 to 2026
$4.5M
The Nebraska Pediatric Clinic Trials UnitUG1OD024953 · OD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Bradford A Brabec, Ellen Kerns · 2016 to 2026
$4.4M
Trials and ReseArch Network FOR even More- South Carolina (TRANSFORM-3)UG1OD024956 · OD · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI ANDREW M ATZ, Lisa Knight · 2016 to 2026
$4.3M
Arkansas ECHO ISPCTN Site (AREIS)UG1OD024945 · OD · ARKANSAS CHILDREN'S HOSPITAL RES INST · PI Stacie M Jones, Tamara Taylor Perry · 2016 to 2026
$4.3M
The Oklahoma Pediatric Clinical Trials NetworkUG1OD024950 · OD · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Amanda L Bogie, Jeanie Beatrice Tryggestad · 2016 to 2026
$4.1M
West Virginia Pediatric Clinical Trials Network - 3UG1OD030016 · OD · WEST VIRGINIA UNIVERSITY · PI MARGARET JAYNES, LEE A PYLES · 2020 to 2026
$2.9M
NIH HHS U24 OD024957NIH HHS UG1 OD024942NIH HHS UG1 OD024943NIH HHS UG1 OD024945NIH HHS UG1 OD024950NIH HHS UG1 OD024953NIH HHS UG1 OD024956NIH HHS UG1 OD024958NIH HHS UG1 OD030016
6 · The paper itself

Abstract

Background/Objective: Prior to the COVID-19 pandemic, our research group initiated a pediatric practice-based randomized trial for the treatment of childhood obesity in rural communities. Approximately 6 weeks into the originally planned 10-week enrollment period, the trial was forced to pause all study activity due to the COVID-19 pandemic. This pause necessitated a substantial revision in recruitment, enrollment, and other study methods in order to complete the trial using virtual procedures. This descriptive paper outlines methods used to recruit, enroll, and manage clinical trial participants with technology to obtain informed consent, obtain height and weight measurements by video, and maintain participant engagement throughout the duration of the trial. Methods: The study team reviewed the IRB records, protocol team meeting minutes and records, and surveyed the site teams to document the impact of the COVID-19 shift to virtual procedures on the study. The IRB approved study changes allowed for flexibility between clinical sites given variations in site resources, which was key to success of the implementation. Results: All study sites faced a variety of logistical challenges unique to their location yet successfully recruited the required number of patients for the trial. Ultimately, virtual procedures enhanced our ability to establish relationships with participants who were previously beyond our reach, but presented several challenges and required additional resources. Conclusion: Lessons learned from this study can assist other study groups in navigating challenges, especially when recruiting and implementing studies with rural and underserved populations or during challenging events like the pandemic.

Indexed as

decentralized clinical trialsobesityPediatricremote clinical trialsrural

Identifiers

PMID36285019
PMCPMC9549582
OpenAlexW4293224742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.